Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
While effective for glycemic control and weight management, these mechanisms can limit nutrient intake and affect absorption
If you do drink, opt for low-sugar options like dry wine or spirits without mixers
It also contains anti-bacterial properties along with macro-nutrients, vitamins and minerals
Trying to manage this on your own is a recipe for trouble